Congratulations to Principal Investigator Amy Erbe-Gurel, PhD, Department of Human Oncology and senior scientist in the Sondel Lab, and mentor Paul Sondel, MD, PhD, professor, Division of Hematology, Oncology, and Bone Marrow Transplant, who were recently awarded a one-year, $45,000 grant from the Health and Environmental Sciences Institute (HESI) through its THRIVE program for the project “Bispecific SNIPER Antibody to Reduce Off-Target Toxicities for Neuroblastoma Tumors.” The goal of this project is to develop more effective and less toxic therapeutic strategies for patients with neuroblastoma, to provide comparable or better anti-tumor efficacy as can be achieved with dinutuximab, and to mitigate pain via novel protein engineering. The THRIVE program funds basic science, clinical, and translational research that enhances clinicians’ ability to predict when and how adverse effects may occur in patients receiving cancer treatment. The program supports the development of approaches to avoid or lessen these adverse effects.